Prognostic value of pre-therapeutic FDG-PET radiomic analysis in gastro-esophageal junction cancer.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
08 04 2023
Historique:
received: 04 12 2022
accepted: 14 03 2023
medline: 11 4 2023
pubmed: 9 4 2023
entrez: 8 4 2023
Statut: epublish

Résumé

The main aim of this study was to evaluate the prognostic value of radiomic approach in pre-therapeutic

Identifiants

pubmed: 37031233
doi: 10.1038/s41598-023-31587-8
pii: 10.1038/s41598-023-31587-8
pmc: PMC10082755
doi:

Substances chimiques

Fluorodeoxyglucose F18 0Z5B2CJX4D
Radiopharmaceuticals 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5789

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2023. The Author(s).

Références

Ann Nucl Med. 2019 Sep;33(9):657-670
pubmed: 31218571
Eur J Nucl Med Mol Imaging. 2016 May;43(5):983-993
pubmed: 26758726
Br J Radiol. 2012 Sep;85(1017):e694-701
pubmed: 22337686
Tomography. 2022 Apr 13;8(2):1113-1128
pubmed: 35448725
Semin Nucl Med. 2021 Mar;51(2):126-133
pubmed: 33509369
EJNMMI Res. 2016 Dec;6(1):21
pubmed: 26944734
J Nucl Med. 2014 Mar;55(3):414-22
pubmed: 24549286
Clin Nucl Med. 2018 Dec;43(12):887-894
pubmed: 30300200
PLoS One. 2015 Dec 15;10(12):e0145063
pubmed: 26669541
Eur J Cancer. 2018 Nov;103:214-226
pubmed: 30268922
Breast Cancer Res Treat. 2015 Feb;150(1):209-17
pubmed: 25697596
Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1117-1142
pubmed: 30064704
Eur J Nucl Med Mol Imaging. 2017 Feb;44(2):206-214
pubmed: 27613542
BMC Cancer. 2017 Apr 17;17(1):275
pubmed: 28415990
Comput Med Imaging Graph. 2017 Sep;60:42-49
pubmed: 28087102
Eur J Nucl Med Mol Imaging. 2011 Jul;38(7):1191-202
pubmed: 21365252
Head Neck. 2019 Feb;41(2):495-502
pubmed: 30549149
Eur Radiol. 2018 Jan;28(1):428-436
pubmed: 28770406
Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):28-50
pubmed: 31637482
J Nucl Med. 2011 Mar;52(3):369-78
pubmed: 21321270
Clin Radiol. 2012 Feb;67(2):157-64
pubmed: 21943720
Med Phys. 2017 Dec;44(12):6413-6424
pubmed: 28994465
Radiology. 2020 May;295(2):328-338
pubmed: 32154773
Eur J Cancer. 2015 Oct;51(15):2144-2157
pubmed: 26421818
Cancer Res. 2018 Aug 15;78(16):4786-4789
pubmed: 29959149
Eur J Nucl Med Mol Imaging. 2013 Oct;40(11):1662-71
pubmed: 23857457
World J Gastrointest Oncol. 2014 May 15;6(5):112-20
pubmed: 24834141
Eur J Gastroenterol Hepatol. 2009 Sep;21(9):1008-15
pubmed: 19352191
Dis Esophagus. 2019 Apr 1;32(4):
pubmed: 30295752
Abdom Radiol (NY). 2019 Jun;44(6):2048-2058
pubmed: 30116873
Q J Nucl Med Mol Imaging. 2021 Mar;65(1):79-87
pubmed: 30916534
PLoS One. 2019 Mar 28;14(3):e0214299
pubmed: 30921388
Front Oncol. 2020 Nov 27;10:599907
pubmed: 33330097
Phys Med Biol. 2020 Dec 17;65(24):24TR02
pubmed: 32688357
Transl Cancer Res. 2016 Aug;5(4):410-423
pubmed: 30687593

Auteurs

Karim Amrane (K)

Department of Oncology, Regional Hospital of Morlaix, Morlaix, France. kamrane@ch-morlaix.fr.

Philippe Thuillier (P)

Department of Endocrinology, University Hospital of Brest, Brest, France.
UMR Inserm 1304 GETBO, IFR 148, University of Western Brittany, Brest, France.

David Bourhis (D)

UMR Inserm 1304 GETBO, IFR 148, University of Western Brittany, Brest, France.
Department of Nuclear Medicine, University Hospital of Brest, 2 Avenue Foch, 29609, Brest Cedex, France.

Coline Le Meur (C)

Department of Oncology, University Hospital of Brest, Brest, France.

Chloe Quere (C)

Department of Nuclear Medicine, University Hospital of Brest, 2 Avenue Foch, 29609, Brest Cedex, France.

Jean-Christophe Leclere (JC)

Department of Otorhinolaryngology, University Hospital of Brest, Brest, France.

Marc Ferec (M)

Department of Gastroenterology, Regional Hospital of Morlaix, Morlaix, France.

Veronique Jestin-Le Tallec (V)

Department of Oncology, Pasteur Clinic, Brest, France.

Laurent Doucet (L)

Department of Pathology, University Hospital of Brest, Brest, France.

Pierre Alemany (P)

Department of Pathology, Ouestpathology Brest, Brest, France.

Pierre-Yves Salaun (PY)

UMR Inserm 1304 GETBO, IFR 148, University of Western Brittany, Brest, France.
Department of Nuclear Medicine, University Hospital of Brest, 2 Avenue Foch, 29609, Brest Cedex, France.

Jean-Philippe Metges (JP)

Department of Oncology, University Hospital of Brest, Brest, France.

Ulrike Schick (U)

Department of Radiotherapy, University Hospital of Brest, Brest, France.

Ronan Abgral (R)

UMR Inserm 1304 GETBO, IFR 148, University of Western Brittany, Brest, France. ronan.abgral@chu-brest.fr.
Department of Nuclear Medicine, University Hospital of Brest, 2 Avenue Foch, 29609, Brest Cedex, France. ronan.abgral@chu-brest.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH